HSBC analyst Henning Cosman upgrades Ferrari (NYSE:RACE) from Hold to Buy.
Aldeyra’s ADX-2191 Aces Late-Stage Study In Rare Vision Disorder
Aldeyra Therapeutics Inc (NASDAQ:ALDX) achieved the primary endpoint in Part 1 of the Phase 3 GUARD Trial of ADX-2191 (methotrexate injection,…